摘要
目前,医学界普遍承认治疗骨肉瘤的最佳方法是基因治疗,常用的有抑癌基因治疗、反义基因治疗、自杀基因治疗、免疫基因治疗、联合基因治疗等.但是无论哪种基因治疗方法,都必须具备安全的基因载体.骨肉瘤的基因治疗方法近几年有所突破,在广泛应用的基础上,还应进一步强调基因载体的重要性.
At present,the medical profession generally acknowledged the best way to treat osteosarcoma is gene therapy,which includes tumor suppressor gene therapy,antisense gene therapy,suicide gene therapy,immune gene therapy,combined gene therapy,etc.But no matter what kind of gene therapy is that the gene must have a safe carrier.Gene therapy has made a breakthrough in osteosarcoma recently.On the basis of widespread use,we should emphasize the importance of gene vectors.
出处
《国际肿瘤学杂志》
CAS
2015年第1期74-76,共3页
Journal of International Oncology
关键词
骨肉瘤
基因疗法
遗传载体
Osteosarcoma
Gene therapy
Genetic vectors